ADAM33 genetic polymorphisms and risk of atopic dermatitis among Japanese children

Clinical Biochemistry

Volumn 42, Issue 6, 2009, Pages 477-483

  Matsusue, Aya ^a   Kiyohara, Chikako ^b   Tanaka, Keiko ^a   Sasaki, Satoshi ^c   Miyake, Yoshihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

ADAM33; Atopic dermatitis; Genetic susceptibility; Haplotype; Japanese children; SNP

Indexed keywords

ADAM 33 PROTEIN; ADAM PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ATOPIC DERMATITIS; CASE CONTROL STUDY; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAM PROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SEX FACTORS;

EID: 61849183054     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.12.014     Document Type: Article

References (42)

1. Yura A., and Shimizu T. Trends in the prevalence of atopic dermatitis in school children: LONGITUDINAL study in Osaka Prefecture, Japan, from 1985 to 1997. Br. J. Dermatol. 145 (2001) 966-973
2. Williams H.C. Atopic eczema. BMJ 311 (1995) 1241-1242
3. Kulig M., Tacke U., Forster J., et al. Serum IgE levels during the first 6 years of life. J. Pediatr. 134 (1999) 453-458
4. Laske N., and Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels?. Pediatr. Allergy Immunol. 15 (2004) 86-88
5. Cork M.J., Robinson D.A., Vasilopoulos Y., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J. Allergy Clin. Immunol. 118 (2006) 3-21
6. Kiyohara C., Tanaka K., and Miyake Y. Genetic susceptibility to atopic dermatitis. Allergol. Intern. 57 (2008) 39-56
7. Van Eerdewegh P., Little R.D., Dupuis J., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418 (2002) 426-430
8. White J.M. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol. 15 (2003) 598-606
9. Martin J., Eynstone L.V., Davies M., Williams J.D., and Steadman R. The role of ADAM 15 in glomerular mesangial cell migration. J. Biol. Chem. 277 (2002) 33683-33689
10. McFarlane S. Metalloproteases: carving out a role in axon guidance. Neuron 37 (2003) 559-562
11. Hundhausen C., Misztela D., Berkhout T.A., et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102 (2003) 1186-1195
12. Seals D.F., and Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17 (2003) 7-30
13. Yoshinaka T., Nishii K., Yamada K., et al. Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity. Gene 282 (2002) 227-236
14. Hirota T., Hasegawa K., Obara K., et al. Association between ADAM33 polymorphisms and adult asthma in the Japanese population. Clin. Exp. Allergy 36 (2006) 884-891
15. Sakagami T., Jinnai N., Nakajima T., et al. ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population. J. Hum. Genet. 52 (2007) 66-72
16. Kedda M.A., Duffy D.L., Bradley B., O R.E., Hehir, and Thompson P.J. ADAM33 haplotypes are associated with asthma in a large Australian population. Eur. J. Hum. Genet. 14 (2006) 1027-1036
17. Raby B.A., Silverman E.K., Kwiatkowski D.J., Lange C., Lazarus R., and Weiss S.T. ADAM33 polymorphisms and phenotype associations in childhood asthma. J. Allergy Clin. Immunol. 113 (2004) 1071-1078
18. Schedel M., Depner M., Schoen C., et al. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations. Respir. Res. 7 (2006) 91
19. Blakey J., Halapi E., Bjornsdottir U.S., et al. Contribution of ADAM33 polymorphisms to the population risk of asthma. Thorax 60 (2005) 274-276
20. Wang P., Liu Q.J., Li J.S., et al. Lack of association between ADAM33 gene and asthma in a Chinese population. Int. J. Immunogenet. 33 (2006) 303-306
21. Lind D.L., Choudhry S., Ung N., et al. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am. J. Respir. Crit. Care Med. 168 (2003) 1312-1316
22. The database of single nucleotide polymorphisms in Japanese population, http://snp.ims.u-tokyo.ac.jp [accessed December 2008].
23. Cheng L., Enomoto T., Hirota T., et al. Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen. Clin. Exp. Allergy 34 (2004) 1192-1201
24. Ke X., and Cardon L.R. Efficient selective screening of haplotype tag SNPs. Bioinformatics 19 (2003) 287-288
25. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
26. Cogan J.D., Prince M.A., Lekhakula S., et al. A novel mechanism of aberrant pre-mRNA splicing in humans. Hum. Mol. Genet. 6 (1997) 909-912
27. von Ahsen N., and Oellerich M. The intronic prothrombin 19911A > G polymorphism influences splicing efficiency and modulates effects of the 20210G > A polymorphism on mRNA amount and expression in a stable reporter gene assay system. Blood 103 (2004) 586-593
28. Onouchi Y., Gunji T., Burns J.C., et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat. Genet. 40 (2008) 35-42
29. Powell R.M., Wicks J., Holloway J.W., Holgate S.T., and Davies D.E. The splicing and fate of ADAM33 transcripts in primary human airways fibroblasts. Am. J. Respir. Cell Mol. Biol. 31 (2004) 13-21
30. Girolomoni G., Sebastiani S., Albanesi C., and Cavani A. T-cell subpopulations in the development of atopic and contact allergy. Curr. Opin. Immunol. 13 (2001) 733-737
31. Ito I., Laporte J.D., Fiset P.O., et al. Downregulation of a disintegrin and metalloproteinase 33 by IFN-gamma in human airway smooth muscle cells. J. Allergy Clin. Immunol. 119 (2007) 89-97
32. Umland S.P., Garlisi C.G., Shah H., et al. Human ADAM33 messenger RNA expression profile and post-transcriptional regulation. Am. J. Respir. Cell Mol. Biol. 29 (2003) 571-582
33. Foley S.C., Mogas A.K., Olivenstein R., Fiset P.O., Chakir J., Bourbeau J., et al. Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J. Allergy Clin. Immunol. 119 (2007) 863-871
34. Howard T.D., Postma D.S., Jongepier H., et al. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 112 (2003) 717-722
35. Werner M., Herbon N., Gohlke H., et al. Asthma is associated with single-nucleotide polymorphisms in ADAM33. Clin. Exp. Allergy 34 (2004) 26-31
36. Ke X., and Cardon L.R. Efficient selective screening of haplotype tag SNPs. Bioinformatics 19 (2003) 287-288
37. Toniolo P, Boffetta P, Shuker DEG, et al. Application of biomarkers in cancer epidemiology. IARC Scientific Publications no 142, 1997.
38. Vineis P, Malats N, Lang M, et al. Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publications no 148, 1999.
39. Todd J.A. Interpretation of results from genetic studies of multifactorial diseases. Lancet 354 Suppl 1 (1999) SI15-16
40. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1513-1530
41. Caporaso N.E. Why have we failed to find the low penetrance genetic constituents of common cancers?. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1544-1549
42. Brennan P. Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it?. Carcinogenesis 23 (2002) 381-387